Literature DB >> 9886545

A longitudinal study of maternal serum inhibin-A, inhibin-B, activin-A, activin-AB, pro-alphaC and follistatin during pregnancy.

P A Fowler1, L W Evans, N P Groome, A Templeton, P G Knight.   

Abstract

Maternal serum concentrations of inhibin-A, inhibin-B, activin-A, activin-AB, pro-alphaC-related inhibin forms, total follistatin, steroids and gonadotrophins were measured longitudinally in six normal singleton pregnancies. Maternal venous blood was collected randomly during a spontaneous follicular phase prior to donor insemination, at 5, 7, 9, 11, 16, 20, 24, 28, 32 and 36 weeks after the first missed menses and in the early puerperium. Steroid and gonadotrophin profiles conformed to previous reports. While at week 5 of gestation inhibin-A, activin-A and follistatin concentrations were similar to those at the follicular phase, all three increased progressively (P < 0.001) to maximal concentrations in week 36: approximately 48-fold (3740 +/- 1349 ng inhibin-A/ml), approximately 22-fold (6109 +/- 1443 ng activin-A/ml) and approximately 10-fold (3563 +/- 418 ng follistatin/ml) higher. Pro-alphaC concentrations reached a maximum in weeks 5 (approximately 5-fold, P < 0.001) and 36 (1027 +/- 174 pg/ml, P < 0.01). Inhibin-B (71 +/- 23 pg/ml prior to pregnancy) was undetectable (<12 pg/ml) between week 5-16 of gestation but increased slightly in the third trimester (26 +/- 7 pg/ml in week 36). Activin-AB was undetectable throughout pregnancy. Post-partum concentrations of inhibin-A (41 +/- 12 ng/ml), inhibin-B (<12 pg/ml), activin-A (950 +/- 149 pg/ml), pro-alphaC (128 +/- 22 pg/ml) and follistatin (990 +/- 79 ng/ml) were substantially lower than at week 36 of gestation. The activin-A:follistatin ratio increased from 0.5 in week 5 to 1.8 in week 36, suggesting that more free activin-A is available in the maternal circulation during late pregnancy.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9886545     DOI: 10.1093/humrep/13.12.3530

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  13 in total

1.  Secretion of inhibin A and inhibin B during pregnancy and early postpartum period in Japanese monkeys.

Authors:  Chihiro Kojima; Masahiro Kondo; WanZhu Jin; Keiko Shimizu; Mariko Itoh; Gen Watanabe; N P Groome; Kazuyoshi Taya
Journal:  Endocrine       Date:  2002-06       Impact factor: 3.633

2.  Upregulated INHBA expression may promote cell proliferation and is associated with poor survival in lung adenocarcinoma.

Authors:  Christopher W Seder; Wibisono Hartojo; Lin Lin; Amy L Silvers; Zhuwen Wang; Dafydd G Thomas; Thomas J Giordano; Guoan Chen; Andrew C Chang; Mark B Orringer; David G Beer
Journal:  Neoplasia       Date:  2009-04       Impact factor: 5.715

3.  Inhibin/activin subunits alpha, beta-A and beta-B are differentially expressed in normal human endometrium throughout the menstrual cycle.

Authors:  Ioannis Mylonas; Udo Jeschke; Irmgard Wiest; Anna Hoeing; Julia Vogl; Naim Shabani; Christina Kuhn; Sandra Schulze; Markus S Kupka; Klaus Friese
Journal:  Histochem Cell Biol       Date:  2004-10-12       Impact factor: 4.304

4.  Umbilical Vein and Maternal Serum Inhibin A, Activin A, and Follistatin Concentrations in IUGR due to Placental Dysfunction Pregnancies.

Authors:  Sravanthi Kasam; Zongji Shen; Hui Cao; Madisetty Venkat Sudeep
Journal:  J Obstet Gynaecol India       Date:  2013-04-16

5.  Activin-A in myometrium: characterization of the actions on myometrial cells.

Authors:  Pasquapina Ciarmela; Ezra Wiater; Wylie Vale
Journal:  Endocrinology       Date:  2008-01-31       Impact factor: 4.736

6.  Endocrinologic comparison of activin a secretion during pregnancy and early lactation in Japanese monkeys, chimpanzees, and humans.

Authors:  Masahiro Kondo; Chihiro Kojima; Gen Watanabe; Keiko Shimizu; Mariko Itoh; Toshifumi Udono; Kazuyoshi Taya
Journal:  Endocrine       Date:  2003-12       Impact factor: 3.633

7.  Physiologic variations of serum tumor markers in gynecological malignancies during pregnancy: a systematic review.

Authors:  Sileny N Han; Anouk Lotgerink; Mina Mhallem Gziri; Kristel Van Calsteren; Myriam Hanssens; Frédéric Amant
Journal:  BMC Med       Date:  2012-08-08       Impact factor: 8.775

8.  Role of activins in embryo implantation and diagnosis of ectopic pregnancy: a review.

Authors:  Bassem Refaat
Journal:  Reprod Biol Endocrinol       Date:  2014-11-25       Impact factor: 5.211

9.  Maternal smoking and developmental changes in luteinizing hormone (LH) and the LH receptor in the fetal testis.

Authors:  Paul A Fowler; Siladitya Bhattacharya; Jörg Gromoll; Ana Monteiro; Peter J O'Shaughnessy
Journal:  J Clin Endocrinol Metab       Date:  2009-10-16       Impact factor: 5.958

10.  Activin A and follistatin as biomarkers for ectopic pregnancy and missed abortion.

Authors:  Alexandros Daponte; Efthimios Deligeoroglou; Antonios Garas; Spyros Pournaras; Christos Hadjichristodoulou; Ioannis E Messinis
Journal:  Dis Markers       Date:  2013-10-07       Impact factor: 3.434

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.